| Application no. and date | 17778663.9 (espacenet) (Federated) (European Patent Register), 20170406 | | Patent/reg. no. and date | DK/EP 3441389, 20210908 | | Publication date | 20190213 | | Priority no. and date | CN 201610210422, 20160406 | | EP pub. no. and date |
EP 3441389 20190213 | | Effective date | | | Applicant/owner | Shanghai Zhimeng Biopharma, Inc., Room A302, A304, Building 1,1976 Gaoke Middle Road
China (Shanghai) Pilot Free Trade Zone
Pudong New Area
Shanghai 201210, CN | | Applicant ref. no. | LUPV1438214/EP-DK-LIB | | Inventor | CHEN, Huanming, Room 21-801
300 Jinxiu Road
Pudong, Shanghai 200135, CN | | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | | Opponent | | | IPC Class | A61K 31/422 (2006.01) , A61K 31/428 (2006.01) , A61P 31/20 (2006.01) , C07D 413/04 (2006.01) , C07D 413/14 (2006.01) , C07D 417/14 (2006.01) | | Title | PYRAZOL-OXAZOLIDINONFORBINDELSE MOD ANTI-HEPATITIS B-VIRUS | | Int. application no. | CN2017079552 | | Int. publication no. | WO2017173999 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
